Combined use of Orgaran and Reopro during coronary angioplasty in patientsunable to receive heparin

Authors
Cantor, WJ Leblanc, K Garvey, B Watson, KR Rasymas, A Strauss, BH
Citation
Wj. Cantor et al., Combined use of Orgaran and Reopro during coronary angioplasty in patientsunable to receive heparin, CATHET C IN, 46(3), 1999, pp. 352-355
Citations number
21
Categorie Soggetti
Cardiovascular & Respiratory Systems
Journal title
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
ISSN journal
15221946 → ACNP
Volume
46
Issue
3
Year of publication
1999
Pages
352 - 355
Database
ISI
SICI code
1522-1946(199903)46:3<352:CUOOAR>2.0.ZU;2-F
Abstract
Orgaran, a heparinoid, has been used successfully in patients with heparin- Induced thrombocytopenia. We report three cases in which Orgaran was combin ed with the glycoprotein Ilb/IIa receptor antagonist Reopro during coronary angioplasty. Orgaran was given as a single intravenous bolus of 1500 anti- factor Xa units. No ischemic or hemorrhagic complications occurred during o r following the procedure. (C) 1999 Wiley-Liss, Inc.